ZAP-70 expression is associated with increased risk of autoimmune cytopenias in CLL patients

Roberta Zanotti, Franzesco Frattini, Paolo Ghia, Carlo Visco, Alberto Zamò, Omar Perbellini, Stefania Stella, Monica Facco, Ilaria Giaretta, Marco Chilosi, Giovanni Pizzolo, Achille Ambrosetti

Research output: Contribution to journalArticlepeer-review


Autoimmune cytopenias (AIC) are frequent in chronic lymphocytic leukemia (CLL) patients, but risk factors and prognostic relevance of these events are controversial. Data about the influence on AIC of biological prognostic markers, as ZAP-70, are scanty. We retrospectively evaluated AIC in 290 CLL patients tested for ZAP-70 expression by immunohistochemistry on bone marrow biopsy at presentation. They were 185 men, median age 63 years, 77.9% Binet stage A, 17.6% B and 4.5% C. AIC occurred in 46 patients (16%): 31 autoimmune hemolytic anemias, 10 autoimmune thrombocytopenias, four Evans syndromes, and one pure red cell aplasia. Of the 46 cases of AIC, 37 (80%) occurred in ZAP-70 positive patients and nine (20%) in ZAP-70 negatives. ZAP-70 expression [Hazard Ratio (HR) = 7.42; 95% confidence interval (CI): 2.49-22.05] and age >65 years (HR = 5.41; 95% CI: 1.67-17.49) resulted independent risk factors for AIC. Among the 136 patients evaluated both for ZAP-70 expression and IGHV status, the occurrence of AIC was higher in ZAP-70 positive/IGHV unmutated cases (35%) than in patients ZAP-70 negative/IGHV mutated (6%) or discordant for the two parameters (4%; P <0.0001). In ZAP-70 positive patients, occurrence of AIC negatively influenced survival (HR = 1.75; 95% CI: 1.06-2.86). The high risk of developing AIC in ZAP-70 positive CLL, particularly when IGHV unmutated, should be considered in the clinical management.

Original languageEnglish
Pages (from-to)494-498
Number of pages5
JournalAmerican Journal of Hematology
Issue number7
Publication statusPublished - Jul 2010

ASJC Scopus subject areas

  • Hematology


Dive into the research topics of 'ZAP-70 expression is associated with increased risk of autoimmune cytopenias in CLL patients'. Together they form a unique fingerprint.

Cite this